It really doesnt look good short term for this stock. I wouldnt be surprised to see it head south of 2 maybe it will have some support around 1.8. I will think about reentering at these levels. i cant see them reaching their 700 tests a year target not a a price of $200, just way too expensive in this economic climate. People really dont take their health into consideration as much as they should in Australia and especially for a heart check. Im onn the sidelines until sub 2 im afraid.
It really doesnt look good short term for this stock. I wouldnt...
Add to My Watchlist
What is My Watchlist?
